LGR5 marks targetable tumor-initiating cells in mouse liver cancer
Cancer stem cells (CSCs) are thought to be the main drivers for disease progression and treatment resistance in liver cancer. This study identifies the LGR5+ compartment as an important CSC population, representing a viable therapeutic target for combating liver cancer.
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/71ee0de1c34f4f6fa934afafed4f5a27 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|